Literature DB >> 27432612

Diagnosis of primary headache in children younger than 6 years: A clinical challenge.

Roberto Torriero1, Alessandro Capuano1, Rosanna Mariani2, Roberto Frusciante1, Samuela Tarantino1, Laura Papetti1, Federico Vigevano1, Massimiliano Valeriani1,3.   

Abstract

Background Criteria defined by the International headache Society are commonly used for the diagnosis of the different headache types in both adults and children. However, some authors have stressed some limits of these criteria when applied to preschool age. Objective Our study aimed to describe the characteristics of primary headaches in children younger than 6 years and investigate how often the International Classification of Headache Disorders (ICHD) criteria allow a definitive diagnosis. Methods This retrospective study analysed the clinical feature of 368 children younger than 6 years with primary headache. Results We found that in our patients the percentage of undefined diagnosis was high when either the ICHD-II or the ICHD-III criteria were used. More than 70% of our children showed a duration of their attacks shorter than 1 hour. The absence of photophobia/phonophobia and nausea/vomiting significantly correlate with tension-type headache (TTH) and probable TTH. The number of first-degree relatives with migraine was positively correlated to the diagnosis of migraine in the patients ( p < 0.001). Conclusions Our study showed that the ICHD-III criteria are difficult to use in children younger than 6 years. The problem is not solved by the reduction of the lowest duration limit for the diagnosis of migraine to 1 hour, as was done in the ICHD-II.

Entities:  

Keywords:  ICHD criteria; Paediatric headache; migraine; tension-type headache

Mesh:

Year:  2016        PMID: 27432612     DOI: 10.1177/0333102416660533

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  7 in total

Review 1.  Migraine in Children Under 7 Years of Age: a Review.

Authors:  Vincenzo Raieli; Antonina D'Amico; Ettore Piro
Journal:  Curr Pain Headache Rep       Date:  2020-12-16

2.  Primary headaches in children and adolescents - experiences at a single headache center in Korea.

Authors:  Yun Jin Jeong; Yun Tae Lee; In Goo Lee; Ji Yoon Han
Journal:  BMC Neurol       Date:  2018-05-21       Impact factor: 2.474

3.  Associations between migraine occurrence and the effect of aura, age at onset, family history, and sex: A cross-sectional study.

Authors:  Yu-Wei Hsu; Chih-Sung Liang; Jiunn-Tay Lee; Hsuan-Te Chu; Meei-Shyuan Lee; Chia-Lin Tsai; Guan-Yu Lin; Yu-Kai Lin; Tsung-Han Ho; Fu-Chi Yang
Journal:  PLoS One       Date:  2020-02-05       Impact factor: 3.240

4.  Prevalence and burden of headache in children and adolescents in Austria - a nationwide study in a representative sample of pupils aged 10-18 years.

Authors:  Julia Philipp; Michael Zeiler; Christian Wöber; Gudrun Wagner; Andreas F K Karwautz; Timothy J Steiner; Çiçek Wöber-Bingöl
Journal:  J Headache Pain       Date:  2019-11-06       Impact factor: 7.277

Review 5.  From the New Diagnostic Criteria to COVID-19 Pandemic Passing Through the Placebo Effect. What Have We Learned in the Management of Pediatric Migrane Over the Past 5 Years?

Authors:  Laura Papetti; Samuela Tarantino; Fabiana Ursitti; Romina Moavero; Martina Checchi Proietti; Giorgia Sforza; Gabriele Monte; Michela Ada Noris Ferilli; Martina Balestri; Federico Vigevano; Massimiliano Valeriani
Journal:  Front Neurol       Date:  2022-07-13       Impact factor: 4.086

Review 6.  Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment.

Authors:  Parisa Gazerani
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

7.  Clinical characteristics of headache in Italian adolescents aged 11-16 years: a cross-sectional questionnaire school-based study.

Authors:  Thomas Foiadelli; Alessandra Piccorossi; Lucia Sacchi; Mara De Amici; Maurizio Tucci; Ilaria Brambilla; Gian Luigi Marseglia; Salvatore Savasta; Alberto Verrotti
Journal:  Ital J Pediatr       Date:  2018-04-04       Impact factor: 2.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.